David E Liddle
CIK 1212726 · last filed 2021-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GWRE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
229 WEST 43RD ST
NEW YORK, NY 10036
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INPHI Corp (IPHI) Delisted | Director | 1,478 | $172.27 | $254.6K | -$49.7K | 10 | 2021-04-20 |
| Intersect ENT, Inc. (XENT) Delisted | 10%+ Owner | 1,995,433 | $28.24 | $56.35M | $0 | 1 | 2015-05-11 |
| NYT | Director | 0 | $70.17 | $0 | -$33.4K | 9 | 2015-05-08 |
| ATRC | 10%+ Owner | 11,873 | $61.25 | $727.2K | $0 | 1 | 2012-06-14 |
| GWRE | 10%+ Owner | 8,722,862 | $162.59 | $1.42B | -$910.77M | 1 | 2012-04-25 |
| IMPERVA INC (IMPV) Delisted | 10%+ Owner | 19,206 | — | — | $0 | 1 | 2011-11-15 |
| MXL | Director | 0 | $67.47 | $0 | -$362.5K | 3 | 2011-05-26 |
Recent Filings · Page 3 of 3
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-04-28 | NYT | Grant (A) | — | $0 | EDGAR |
| 2010-04-29 | NYT | Grant (A) | — | $0 | EDGAR |
| 2010-03-25 | MXL | Grant (A) | — | $0 | EDGAR |
| 2009-12-07 | — | Sell (S) | −2,600 | -$10.9K | |
| 2009-04-24 | NYT | Grant (A) | — | $0 | EDGAR |
| 2008-04-23 | NYT | Grant (A) | — | $0 | EDGAR |
| 2007-04-26 | NYT | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.